A: Semaglutide is injected once weekly under the skin, on the same day each week, as prescribed by a doctor
We look forward to creating your personalized plan to help you achieve your weight loss and wellness goals
About 1.6 million adults in England, Wales and Scotland used GLP-1 medication, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro), between early 2024 and early 2025 to lose weight, according to recent research
Additionally, GLP1R agonists have shown anti-inflammatory effects in the cardiovascular diseases 20,21
Among these, obesity (defined by the WHO as a body mass index (BMI) 30 kg/m 2 ) [6], is characterized by low-grade inflammation driven by adipokine secretion from adipose tissue